Connect with us

International

EVs Have Taken Off – Which of 2 Electric Car Stocks to Buy and Sell

A Tale of 2 Electric Car Stocks – 1 to Buy, and 1 to Sell

Published

on

This article was originally written by TipRanks.

COVID-19 wasn’t always the talk of the Street. The rapid pace of climate change has made finding renewable energy sources and limiting pollution more important than ever before, and as such, the spotlight has landed on electric car companies. Already making some serious headway, demand is expected to persist in the long-term as more and more countries roll out programs designed to encourage the purchase of these vehicles. According to a report published by Cairn Energy Research Advisors, a research firm focused on the battery and electric vehicle (EV) industries, in 2021, global sales of EVs are expected to exceed 3 million for the first time ever. The implication? Major gains could be in store for stocks belonging to this burgeoning space. That being said, analysts remind investors that not all EV stocks are created equal, with some significantly more compelling than others. Taking this into consideration, we used TipRanks’ database to take a closer look at two EV stocks that have received quite a bit of attention recently. As it turns out, one has scored rave reviews from some analysts, while the other gets a thumbs down. Nikola Corporation (NKLA) Specializing in the production of electric and hydrogen-powered semi-trucks, Nikola is also working on an alternative-fuel pickup truck called the Badger, a network of sustainable hydrogen fueling stations and electric recreational vehicles. Despite the significant drop posted by shares over the last month, some members of the Street believe that several potential catalysts could propel it forward. Calling NKLA a “story-stock”, J.P. Morgan analyst Paul Coster points out it is “trading on a massive multiple of distant-future earnings.” In turn, this has caused investors to focus on the potential pitfalls, but he argues it’s also “worth dwelling on what could go right here, which is that the company executes to plan, captures a significant share of the global truck market, and emerges as a key infrastructure provider in a future Hydrogen-based economy.” He also stated, “If the company does execute to plan, then investors will be holding a stock that systematically de-risks with each passing implementation milestone, which could lead to a lower discount rate.” Offering an explanation for the recent volatility, Coster notes that trading volumes are currently very high even though float is limited. The analyst has interpreted this to mean that the stock movement has been driven by short-term traders, with institutional investor focus landing primarily on warrants. “We sense that the stock will remain volatile until the SPAC shares are registered and the warrant calls are exercised (by the company), which could lead to some additional selling (easily absorbed by current trading volumes), and then some degree of stabilization as the stock finds its way to higher conviction investors,” Coster explained. As for recent developments that bode well for NKLA, the European Commission unveiled its plans to promote clean hydrogen, as part of the Green Deal economic recovery plan. Hyundai has already started shipping (10) hydrogen XCIENT fuel cell trucks to Switzerland, with the goal of selling 1,600 FCEL vehicles by 2025. What does this mean? According to Coster, it sets the bar high for NKLA. In addition, initial demand for the Badger BEV pickup truck has been robust. Adding to the good news, the company is expected to announce an OEM partner for the Badger truck, an H2 station deployment plan for the UK and possibly even accelerated implementation plans for the FCEL truck in the U.S. Coster added, “California’s CARB ACT ruling could lead to accelerated adoption of H2 infrastructure on the West Coast, beyond Nikola’s original plan. We think the stock will react favorably to any developments that shorten and/or de-risk the BEV and FCEL truck implementation plans.” In line with his optimistic take, Coster stepped over to the bulls’ side. In addition to upgrading the rating from Neutral to Overweight, he put a $45 price target on the stock. A twelve-month gain of 50% could be in store, should the analyst’s thesis play out in the year ahead. (To watch Coster’s track record, click here) Turning now to the rest of the Street, opinions are split evenly. 2 Buys and 2 Holds add up to a Moderate Buy consensus rating. At $56, the average price target is more aggressive than Coster’s and brings the upside potential to 87%. (See Nikola stock analysis on TipRanks)
Nio (NIO) As for the other EV stock on our list, Nio shares have been charging forward, with it already having gained 199% since the start of 2020. That being said, some analysts believe that there isn’t any more fuel left in the tank. Not long ago, Goldman Sachs analyst Fei Fang was bullish on the stock. At the beginning of June, the analyst upgraded Nio to Buy before it reported its vehicle deliveries. The company was able to deliver 3,436 vehicles in May, which reflected a year-over-year gain of 215.5% and blew estimates out of the water. While this achievement was a new record for the company, Fang started seeing problems with NIO’s long-term growth narrative. On top of this, NIO reported that despite the impacts of the COVID-19 pandemic, June sales climbed 179% higher from the prior-year period. Not to mention the EV maker saw quarterly shipments exceed 10,000 for the first time in its history. This was met by applause from investors, but Fang became worried that the valuation was skyrocketing too high. And thus, although the underlying fundamentals are strong, the analyst stepped onto the sidelines. Now, Fang believes the stock has surged enough for now. “Post the 89% share price rally in the past month, we downgrade NIO to Sell on valuation, as we believe the current share price reflects over-optimism given no substantial changes to volume/profit expectations,” the analyst explained. It should be noted that since the pandemic’s onset, Nio has secured funding and gotten cash infusions that “have largely removed any liquidity risk for the company between now and our expected break-even in 2022E.” Additionally, several factors would make Fang more optimistic about the company’s growth prospects. “Successful deployment of these resources could lead to faster product launches, which could expand demand and accelerate break-even,” Fang stated. He also noted, “The Nio brand’s positioning provides the premium pricing power that we expect the company to leverage across model cycles and powertrain technologies.” Due to all of the above, Fang joined the Nio bears. Along with the call, a $7 price target is left on the stock. This figure implies shares could decline 41% in the next year. (To watch Fang’s track record, click here) Looking at the consensus breakdown, 2 Buys, 2 Holds and 2 Sells have been assigned in the last three months. So, NIO gets a Hold consensus rating. Given the $7.26 average price target, the downside potential comes in at 39%. (See Nio stock analysis on TipRanks)
The post A Tale of 2 Electric Car Stocks – 1 to Buy, and 1 to Sell appeared first on TipRanks Financial Blog.

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending